Antony C. Mattessich, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), sold 36,676 shares at $4.95 ($182K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Open-market sale of $182k OCUL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.95 | 18,338 | $91K | 50.0% |
| 2 | $4.95 | 18,338 | $91K | 50.0% |
| Total | $4.95 avg | 36,676 | $182K | 100% |
| Filing → |
| OCUL | SELL | 2023-02-08 | $167K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |
| OCUL | BUY | 2019-06-10 | $112K | — | Filing → |